US WorldMeds and Salix Pharmaceuticals, a wholly owned subsidiary of Bausch Health Companies, announced the U.S. launch and availability of Lucemyra, or lofexidine, 0.18 mg tablets, the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.